Acta Haematologica

Papers
(The TQCC of Acta Haematologica is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-07-01 to 2024-07-01.)
ArticleCitations
Systematic Review of Microthrombi in COVID-19 Autopsies37
Immune Dysfunction in Patients with Chronic Lymphocytic Leukemia and Challenges during COVID-19 Pandemic27
Accelerated Phase of Myeloproliferative Neoplasms26
Red Blood Cell Distribution Is a Significant Predictor of Severe Illness in Coronavirus Disease 201926
Hematological Manifestations among Patients with Rheumatic Diseases23
Coronavirus Disease 2019 (COVID-19): A Haematologist’s Perspective19
A Phase II Study of Azacitidine, Venetoclax, and Trametinib in Relapsed or Refractory Acute Myeloid Leukemia Harboring RAS Pathway-Activating Mutations18
COVID-19 Coagulopathy: From Pathogenesis to Treatment18
G-CSF and GM-CSF Are Different. Which One Is Better for COVID-19?16
Tapering and Discontinuation of Thrombopoietin Receptor Agonist Therapy in Patients with Immune Thrombocytopenia: Results from a Modified Delphi Panel16
Current Treatment of Refractory/Relapsed Chronic Lymphocytic Leukemia: A Focus on Novel Drugs13
JAK/STAT Pathway Inhibition May Be a Promising Therapy for COVID-19-Related Hyperinflammation in Hematologic Patients12
The Efficacy of Etoposide-Based Therapy in Adult Secondary Hemophagocytic Lymphohistiocytosis11
Adherence to Immunization: Rebuttal of Vaccine Hesitancy10
ALK-Positive Histiocytosis with Peripheral Blood Histiocytes: A Case Report10
Management of Persistent SARS-CoV-2 Infection in Patients with Follicular Lymphoma10
Discontinuation of Maintenance Tyrosine Kinase Inhibitors in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia outside of Transplant10
Current Understandings of Myeloid Differentiation Inducers in Leukemia Therapy9
<b><i>BCR/ABL1</i></b>-Like Acute Lymphoblastic Leukemia: From Diagnostic Approaches to Molecularly Targeted Therapy9
Consolidation Treatment for Primary Central Nervous System Lymphoma: Which Modality for Whom?9
Pure Red Cell Aplasia following ABO-Mismatched Allogeneic Hematopoietic Stem Cell Transplantation: Resolution with Daratumumab Treatment8
Low Prevalence of Antibodies to SARS-CoV-2 and Undetectable Viral Load in Seropositive Blood Donors from South-Eastern Italy8
COVID-19 in Patients with Hematologic Malignancies: Clinical Manifestations, Persistence, and Immune Response8
Is G-CSF Dangerous in COVID-19: Why Not Use GM-CSF?8
Clonal Megakaryocyte Dysplasia with Normal Blood Values Is a Distinct Myeloproliferative Neoplasm8
Viscoelastic Coagulation Monitor (VCM<sup>Vet</sup>) Reference Intervals and Sex Differences in Mature Adult Mice8
Real-World Use of Fostamatinib in Patients with Immune Thrombocytopenia and Thrombotic Risk8
Photon Counting Detector Computed Tomography: A New Frontier of Myeloma Bone Disease Evaluation7
Deoxycytidine Kinase (DCK) Mutations in Human Acute Myeloid Leukemia Resistant to Cytarabine7
Ruxolitinib for Severe COVID-19-Related Hyperinflammation in Nonresponders to Steroids7
Current and Emerging Treatments for Waldenström Macroglobulinemia7
Kinase Inhibitors and Interferons as Other Myeloid Differentiation Inducers in Leukemia Therapy7
Vaccination for SARS-CoV-2 in Hematological Patients7
Ibrutinib in Advanced Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: Lower Risk of Hepatitis B Virus Reactivation6
Tocilizumab Treatment Effect on Iron Homeostasis in Severe COVID-19 Patients6
Prognostic Impact of Peripheral Blood T-Cell Subsets at the Time of Diagnosis on Survival in Patients with Diffuse Large B-Cell Lymphoma6
Dramatic Recovery after Etoposide Phosphate Infusion for Hemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome following Treatment with Tisagenlecleucel in a Young Patient with Relapsed Ac6
Relationship of Thrombospondin 1 to von Willebrand Factor and ADAMTS-13 in Sickle Cell Disease Patients of Arab Ethnicity6
COVID-19 in Patients with Hematologic Malignancies: Outcomes and Options for Treatments6
An Early Unexpected Immune Thrombotic Thrombocytopenic Purpura Relapse Associated with SARS-CoV-2 Infection: A Case Report and Literature Review6
Using Circ-ANAPC7 as a Novel Type of Biomarker in the Monitoring of Acute Myeloid Leukemia5
Pretreatment Immature Platelet Fraction as a Surrogate of Reticulated Platelets Predicts the Response to Corticosteroids in Adults with Immune Thrombocytopenia5
Management of COVID-19 Coagulopathy in a Patient with Severe Haemophilia A5
Efficacy and Incidence of Treatment-Related Adverse Events of Thrombopoietin Receptor Agonists in Adults with Immune Thrombocytopenia: A Systematic Review and Network Meta-Analysis of Randomized Contr5
Two Novel Variants in the Protein S Gene PROS1 Are Associated with Protein S Deficiency and Thrombophilia5
A Case of Hemophagocytic Lymphohistiocytosis following Second Dose of COVID-19 Vaccination5
Absolute Immature Platelet Counts Suggest Platelet Production Suppression during Complicated Relapsing Thrombotic Thrombocytopenic Purpura5
Two Cases of Possible Familial Chronic Myeloid Leukemia in a Family with Extensive History of Cancer4
Concomitant Primary Hyperparathyroidism in Patients with Multiple Myeloma: A Possible Link?4
Successful Treatment of the TEMPI Syndrome with Pomalidomide Plus Dexamethasone Followed by Autologous Stem Cell Transplantation4
Prognostic Markers in the Era of Targeted Therapies4
Progressive Multifocal Leukoencephalopathy in Relapsed Ph+ Acute Lymphoblastic Leukemia after Cord Blood Transplantation and Blinatumomab Treatment: A Case Report and Literature Review4
COVID-19 Infection in Sickle Cell Patients in a Developing Country: A Case Series4
Effectiveness and Safety of Pixantrone for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma in Every-Day Clinical Practice: The Italian Cohort of the PIXA Registry4
Threshold of Serum Ferritin to Discriminate against Those at Greater Risk of Platelet Increase during Treatment with Hypoxia-Inducible Factor Prolyl Hydroxylase Domain Inhibitor4
How Do We Manage Hematopoietic Cell Transplant during the SARS-CoV-2 Pandemic?4
Ruxolitinib Re-Treatment in Patients with Myelofibrosis: Real-World Evidence on Patient Characteristics and Outcomes4
Complete Remission with Incomplete Blood Count Recovery Is a Strong Predictor of Nonrelapse Mortality in Acute Myeloid Leukemia Patients Undergoing Allogeneic Stem Cell Transplantation4
Increased Plasma GDF15 Is Associated with Altered Levels of Soluble VEGF Receptors 1 and 2 in Symptomatic Multiple Myeloma4
Splenectomy Outcomes in Relapsed or Refractory Immune Thrombocytopenia according to First-Line Intravenous Immunoglobulin Response4
Very Early Increased Platelet Count within a Week after Initiation of High-Dose Dexamethasone Treatment Is Associated with Long-Term Response in Newly Diagnosed Immune Thrombocytopenia Patients4
Plasma Exchange as an Initial Treatment for Severe Bleeding Induced by Acquired Factor V Deficiency: A Case Report and Mini Literature Review4
Eltrombopag for the Treatment of Severe Inherited Thrombocytopenia4
Concomitant Immunosuppressive Therapy and Eculizumab Use in Patients with Paroxysmal Nocturnal Hemoglobinuria: An International PNH Registry Analysis4
Survival Disparities in Multiple Myeloma by Health Insurance Status among US Non-Elderly Adults: A SEER-Based Comparative Analysis4
Clinical Significance of Plasma Epstein-Barr Virus DNA in Peripheral T-Cell Lymphomas4
Clonal Megakaryocyte Dysplasia with Isolated Thrombocytosis Is a Distinct Myeloproliferative Neoplasm Phenotype4
Ruxolitinib in COVID-19 Hyperinflammation and Haematologic Malignancies4
Gilteritinib in Isolated Breast Relapse of <b><i>FLT3</i></b> Positive Acute Myeloid Leukemia: A Case Report and Review of Literature4
Efficacy of Individualized Preventive Treatment of Patients with Severe Hemophilia A Guided by Multiple Clinical Parameters and Pharmacokinetics4
Myeloid Sarcoma: Diagnostic and Treatment Tools from a Monocentric Retrospective Experience4
PNH Clones for Aplastic Anemia with Immunosuppressive Therapy: A Systematic Review and Meta-Analysis4
Effects of Glycosaminoglycan from <b><i>Urechis unicinctus</i></b> on ADP-Induced Platelet Calcium and Membrane Glycoprotein Expressions in Rats4
Association between Platelet-Associated Immunoglobulin G Levels and Response to Corticosteroid Therapy in Patients with Newly Diagnosed Immune Thrombocytopenia3
Use of Core-Needle Biopsy for the Diagnosis of Malignant Lymphomas in Clinical Practice3
Safety and Feasibility Analysis of a Prospective Trial on Stereotactic Body Radiotherapy for Solitary Bone Plasmacytoma3
Chronic Lymphocytic Leukemia: Disease Biology3
MiR-199a-3p Overexpression Suppressed Cell Proliferation and Sensitized Chronic Myeloid Leukaemia Cells to Imatinib by Inhibiting mTOR Signalling3
Patient Involvement in the Transfusion Decision-Making Can Change Patient Blood Management Practice for Better or Worse3
The Mechanistic Effects and Clinical Applications of Various Derived Mesenchymal Stem Cells in Immune Thrombocytopenia3
Resolution of Melanoma to Programmed Death-1 Blockade but Simultaneous Rapid Progression of Concomitant Chronic Lymphocytic Leukemia3
Phase II, Multicenter, Single-Arm, Open-Label Study to Evaluate the Efficacy and Safety of Panobinostat in Combination with Bortezomib and Dexamethasone in Japanese Patients with Relapsed or Relapsed-3
Acute Myeloid Leukemia with NPM1 Mutation and Disseminated Leukemia Cutis: Achievement of Molecular Complete Remission by Venetoclax/Azacitidine Combination in a Very Old Patient3
Long-Term Adherence to Direct Oral Anticoagulants in Patients with Atrial Fibrillation: A Comparative Cross-Sectional Study3
Significance of the p.Phe218Ser and p.Gly304Glu F5 Variants in Hereditary Factor V Deficiency3
Increased Incidence of Thrombosis in a Cohort of Cancer Patients with COVID-193
STAT3 Promotes Cell Proliferation by Potentiating the CCL4 Transcriptional Activity in Diffuse Large B-Cell Lymphoma3
Chronic Eosinophilic Leukaemia Associated with <b><i>JAK2</i></b> Exon 13 Insertion/Deletion Mutations3
Stroke Prevention with Hydroxyurea Enabled through Research and Education: A Phase 2 Primary Stroke Prevention Trial in Sub-Saharan Africa3
Cellular Therapy in Chronic Lymphocytic Leukemia: Have We Advanced in the Last Decade?3
Imaging of Hematological Patients in the Era of COVID-192
Extracellular Vesicles Derived from Human Bone Marrow Stem Cells Inhibit Acute Lymphoblastic Leukemia Cell Growth by Inhibiting MAPK Pathway via the miR-29b-3p/GDF15 Axis2
Fostamatinib or Thrombopoietin for the Treatment of Chronic Immune Thrombocytopenia in Adult Patients: A Real-World Assessment of Safety, Effectiveness and Cost2
Cold Agglutinin-Mediated Autoimmune Hemolytic Anemia in Association with Antiphospholipid Syndrome2
Platelet miR-107 Participates in Clopidogrel Resistance after PCI Treatment by Regulating P2Y122
Relapses of Immune Thrombocytopenia after the Second and Booster Doses of BNT162b2 Vaccine2
Effectiveness of Caplacizumab Nanobody in Acquired Thrombotic Thrombocytopenic Purpura Refractory to Conventional Treatment2
Acute Myeloid Leukemia Treatment in the Elderly: A Comprehensive Review of the Present and Future2
Treatment-Free Remission in Real-World Chronic Myeloid Leukemia Patients: Insights from German Hematology Practices2
Non-Immunotherapy Approaches for Relapsed or Refractory AML: An Update for 20242
Acute Promyelocytic Leukemia with del(6)(p22) and Atypical bcr2 PML::RARA Fusion Transcript: A Case Report2
Belantamab Mafodotin and Relapsed/Refractory Multiple Myeloma: This Is Not Game Over2
The Role of Iron Staining in Myelodysplastic Syndromes: A Treasure Trove of Information2
“The Long Journey of Unexplained Erythrocytosis”: Erythrocytosis due to High-Oxygen Affinity Hemoglobinopathy – Hemoglobin Variant Little Rock (HBB: c.432C&gt;A) – A Report of a Swiss Family and R2
Preliminary Study on Apoptotic Proteins in Platelet from Adult Patients with Chronic Immune Thrombocytopenic Purpura2
Optimal Post-Remission Consolidation Therapy in Patients with AML2
Make Family Caregivers Visible, Valued, and Supported: An Interview with Patients’ Caregivers’ Advocate2
Neuropsychiatric Derangement by Polycythemia Vera: A Case Report of an Unexpected Disease Presentation and Review of the Literature2
Distinct Mechanisms of IgM Antibody-Mediated Acquired von Willebrand Syndrome and Successful Treatment with Recombinant von Willebrand Factor in One Patient2
Monitoring Minimal Residual Disease in <b><i>RUNX1</i></b>-Mutated Acute Myeloid Leukemia2
Timing of Initiation of Calcineurin Inhibitors in Pediatric Haploidentical Transplantation with Post-Transplantation Cyclophosphamide: Effects on Survival, Relapse, and Cytokine Release Syndrome2
Total Platelet Transcriptomics and Its Network Analysis by RNA-Seq and miRNA-Seq and PCA Application in Essential Thrombocythaemia2
Physician’s Subjective Increase in Awareness towards Perioperative Anaemia, Patient’s Blood Resource, and Transfusion after the Implementation of Patient Blood Management: A Nationwide Multicentre Sur2
Tanshinone IIA Inhibits Tissue Factor Expression Induced by Thrombin in Human Umbilical Vein Endothelial Cells via PAR-1 and p38 MAPK Signaling Pathway2
Exclusion of Acute Myeloid Leukemia Patients with Central Nervous System Involvement from Clinical Trials: An Analysis of the National Institutes of Health Clinical Trials Registry from 2012 to 20222
A Novel ANK1 Mutation in a Neonatal Hereditary Spherocytosis Case: Diagnostic Challenges and Familial Genetic Analysis2
An Eltrombopag Red (Plasma) Alert2
A Gene Signature Comprising Seven Pyroptosis-Related Genes Predicts Prognosis in Pediatric Patients with Acute Myeloid Leukemia2
Primary Extranodal NK/T-Cell Lymphoma Presenting as Neurolymphomatosis Involving Multiple Cranial Nerves: A Case Report2
Frontline Therapy in Chronic Lymphocytic Leukemia2
A Patient with Kabuki Syndrome Mutation Presenting with Very Severe Aplastic Anemia2
Role of Inherited Thrombophilia Risk Factors in Patients with CKD-5 Receiving Haemodialysis2
The Prognostic Ability of RAS Pathway-Related Gene Mutations in Patients with Myeloid Neoplasms Treated with Hypomethylating Agents2
Myeloid Neoplasm with <b><i>PCM1-PDGFRB</i></b> Transcript Responded to Low-Dose Imatinib: One Case Report with Literature Review2
Antithrombin Activity Is Associated with Persistent Thromboinflammation and Mortality in Patients with Severe COVID-19 Illness2
Successful Treatment of Vaccine-Induced Immune Thrombotic Thrombocytopenia in a 26-Year-Old Female Patient2
Cytokine and Gene Expression Profiling in Patients with <b><i>HFE</i></b>-Associated Hereditary Hemochromatosis according to Genetic Profile2
Prognostic Value of Microvessel Density in Non-Hodgkin Lymphoma: A Meta-Analysis2
Anemia in Celiac Disease: Multiple Aspects of the Same Coin2
Romiplostim for Primary Immune Thrombocytopenia in Routine Clinical Practice: Results from a Multicentre Observational Study in Germany2
High Expression of CD300A Predicts Poor Survival in Acute Myeloid Leukemia2
0.97772479057312